JeffreyHLawsonMD
Vascular Surgery • Durham, NCAssociate Professor, Surgery, Duke University School of Medicine
Dr. Lawson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
Duke University HospitalResidency, Surgery, 1992 - 1999
University of Vermont College of MedicineClass of 1991
Certifications & Licensure
NC State Medical License 1999 - 2025- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Genetics of Peripheral Artery Genomics Start of enrollment: 2004 Jun 01
- Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm Start of enrollment: 2006 May 05
- Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 367 citationsReadily Available Tissue-Engineered Vascular GraftsShannon L. M. Dahl, Alan P. Kypson, Jeffrey H. Lawson, Juliana Blum, Justin T. Strader
Science Translational Medicine. 2011-02-02 - 218 citationsBioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trialsJeffrey H. Lawson, Marc H Glickman, Marek Iłżecki, Tomasz Jakimowicz, Andrzej Jaroszyński
Lancet. 2016-05-14 - 253 citationsDecellularized tissue-engineered blood vessel as an arterial conduitClay Quint, Yuka Kondo, Roberto J. Manson, Jeffrey H. Lawson, Alan Dardik
Proceedings of the National Academy of Sciences of the United States of America. 2011-05-31
Authored Content
- Arterial Reconstruction with Human Bioengineered Acellular Blood Vessels in Patients with Peripheral Arterial DiseaseFebruary 2020
Press Mentions
NCBiotech and UNC FastTraCS Event to Accelerate Patient-Centered InnovationSeptember 19th, 2021
PA Becomes Inventor, Entrepreneur, and InnAVasc Co-FounderAugust 17th, 2018
Humacyte Commences Phase III Clinical Trial of Human Acellular VesselMay 13th, 2016- Join now to see all
Grant Support
- Autologous EPC Lining To Improve Biocompatibility Of Circulatory Assist DevicesNational Heart, Lung, And Blood Institute2009–2010
- Genomics Of Peripheral Arterial DiseaseNational Heart, Lung, And Blood Institute2005–2006
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
